O
AGN.PRA

OppenheimerFunds’s Allergan plc AGN.PRA Stock Holding History

OppenheimerFunds’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-52,947
Closed -$48.7M – 1745
2016
Q1 		$48.7M Buy
+52,947
New +$50.6M 0.06% 320
2015
Q4 		– Sell
-2,970
Closed -$2.8M – 1782
2015
Q3 		$2.8M Buy
+2,970
New +$3.1M ﹤0.01% 839

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

OppenheimerFunds's AGN.PRA Position: Q2 2016 in Review

OppenheimerFunds sold out of Allergan plc (AGN.PRA) in Q2 2016, closing a stake of 52,947 shares — an estimated $48.7M sold.

OppenheimerFunds first reported a position in AGN.PRA in Q3 2015 and held it in 2 quarters. The position peaked at $48.7M in Q1 2016. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2016.

  • OppenheimerFunds reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • OppenheimerFunds sold 52,947 Allergan plc shares in Q2 2016, an estimated $48.7M.
  • OppenheimerFunds first reported a position in Allergan plc in Q3 2015 and held it in 2 quarters.
  • OppenheimerFunds's Allergan plc position peaked at $48.7M in Q1 2016.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on OppenheimerFunds's 13F filing for Q2 2016, filed 11 Aug 2016.